approval
saveWAINUA (AUTOINJECTOR) (EPLONTERSEN SODIUM) — FDA approval
community read0 votes
Sponsor: ASTRAZENECA AB. Form: SOLUTION. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 4
- approvalWAINUA (AUTOINJECTOR) (EPLONTERSEN SODIUM) — FDA approvalDec 17, 2025 · 291d ago
- approvalWAINUA (AUTOINJECTOR) (EPLONTERSEN SODIUM) — FDA approvalApr 18, 2025 · 534d ago
- approvalWAINUA (AUTOINJECTOR) (EPLONTERSEN SODIUM) — FDA approvalSep 25, 2024 · 739d ago
- approvalWAINUA (AUTOINJECTOR) (EPLONTERSEN SODIUM) — FDA approvalDec 21, 2023 · 1018d ago
same company · ±60 days · 6
- approvalnirsevimab: BEYFORTUS (NIRSEVIMAB-ALIP) — FDA approvalApr 7, 2026
- earningsASTRAZENECA PLC earningsApr 29, 2026
- phase 3 completiondurvalumab: AstraZeneca Plc — durvalumab (Phase III Trial Completion)Apr 29, 2026
- phase 2 completiontozorakimab: AstraZeneca Plc — tozorakimab (Phase II Trial Completion)Apr 30, 2026
- fda advisory committee meetingcamizestrant: AstraZeneca Plc — camizestrant (FDA Advisory Committee Meeting)Apr 30, 2026
- fda advisory committee meetingcapivasertib: AstraZeneca Plc — capivasertib (FDA Advisory Committee Meeting)Apr 30, 2026
comments(0)
5-min edit window · permanent after that